HomeATRA • NASDAQ
Follow
Atara Biotherapeutics Inc
Previous close
$0.68
Day range
$0.68 - $0.73
Year range
$0.20 - $3.08
Market cap
85.53M USD
Avg Volume
1.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.20M | 1,345.70% |
Operating expense | 11.30M | 14.96% |
Net income | -65.12M | 12.67% |
Net profit margin | -2.04K | 93.96% |
Earnings per share | -0.56 | 22.22% |
EBITDA | -60.22M | 11.95% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 51.72M | -78.70% |
Total assets | 165.50M | -56.03% |
Total liabilities | 264.74M | 5.99% |
Total equity | -99.23M | — |
Shares outstanding | 119.36M | — |
Price to book | -0.73 | — |
Return on assets | -92.78% | — |
Return on capital | 396.33% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -65.12M | 12.67% |
Cash from operations | -50.88M | 10.56% |
Cash from investing | 40.20M | -21.52% |
Cash from financing | 652.00K | -97.98% |
Net change in cash | -10.03M | -137.66% |
Free cash flow | -27.61M | 54.51% |
About
Founded
2012
Headquarters
Website
Employees
225